Tag: mad in america influence
Robert Whitaker Answers Reader Questions on Pharma Marketing and Psychiatric Drugs
In Part 2 of our reader Q&A podcast, MIA founder Robert Whitaker answers questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy.
Changing Narratives: Reflecting on Mad in America’s Mission and Work
For our 200th podcast interview, we are joined by members of MIA staff to reflect on Mad in America's mission and work over the last decade.
Mad in America: 2018 by the Numbers
As 2019 begins, we at Mad in America are looking forward to continuing to broaden our efforts to provide informational and educational resources that will help our society "rethink psychiatry." The start of the New Year also provides us with an opportunity to look back and tally up our efforts in 2018.
Psychologist Rethinks Psychotropic Medications, Calls for Renewed Dialogue
Psychologist and Professor Amber Gum has published the story of her personal journey of rethinking psychotropic medication in a special issue on "The Politics of Mental Health" in The Journal of Medicine and the Person. Influenced by Mad in America and the work of Robert Whitaker, Gum became aware of evidence that “suggests that psychotropic medications are less effective and more harmful than most believe” and now hopes to encourage other mental health professionals and researchers to engage in open-minded, critical self-assessment of standard practices.
